Researchers at the University of Louisville School of Medicine are using breath analysis to detect the presence of lung cancer.
Preliminary data indicate that this promising noninvasive tool offers the sensitivity of PET scanning, and has almost twice the specificity of PET for distinguishing patients with benign lung disease from those with early stage cancer. Michael Bousamra II, MD, Associate Professor, Department of Cardiovascular and Thoracic Surgery, is presenting the results of the study at the AATS 2014 Conference on April 29, 2014.
A reliable, noninvasive diagnostic method imposes less physical and financial burden on patients who actually have no significant disease, while rapid and accurate diagnosis expedites treatment for patients who truly have lung cancer.
The team believes that while the breath test would not replace CT as a primary screening tool, it would be particularly helpful in conjunction with a positive CT scan result. “This breath analysis method presents the potential for a cheaper and more reliable diagnostic option for patients found to have bulky disease on a CT scan. If the breath analysis is negative, the patient may, in some instances, be followed with repeated exams without necessitating a biopsy. But a positive breath analysis would indicate that the patient may proceed to definitive biopsy, thus expediting treatment,” says Dr. Bousamra.
Investigators used specially coated silicon microchips to collect breath samples from 88 healthy controls, 107 patients with lung cancer, 40 individuals with benign pulmonary disease, and 7 with metastatic lung cancer.
Previous work had pinpointed four specific substances, known as carbonyl compounds, in breath samples as “elevated cancer markers” (ECMs) that distinguish patients with lung cancer from those with benign disease. The carbonyl compounds found in the breath are thought to reflect chemical reactions occurring in malignant lung tumors. In this study, the authors compared the findings from the breath analyses to the results from PET scans.
The investigators found that the sensitivity and specificity of breath analysis depended upon how many of the ECMs were elevated. For example, having 3 or 4 ECMs was diagnostic of lung cancer in 95% of those with this result. The majority of patients with benign pulmonary disease had either 0 or 1 ECM, while those with Stage IV cancer were most likely to have 3 or 4. The number of ECMs could be used to differentiate benign disease from both early and advanced stage lung cancer. Interestingly, 3 of the 4 elevated markers returned to normal levels after cancer resection.
When it comes to differentiating early stage lung cancer from benign pulmonary disease, breath analysis and PET scanning had similar sensitivities (82.8% and 90.3%, respectively). However, breath analysis had a much higher specificity than PET (75% vs. 38.7%, respectively) for distinguishing benign disease, which means that it was much more accurate at identifying those who did not have cancer. This would be an important feature for patients with benign disease, since having a breath analysis rather than PET scan could mean avoiding an unnecessary invasive biopsy procedure later on.
The Latest on: Detect Early Lung Cancer
[google_news title=”” keyword=”Detect Early Lung Cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Detect Early Lung Cancer
- GRAIL, LLC: GRAIL Announces Novel Risk Classification Test to Be Used in Lung Cancer Studyon March 18, 2024 at 7:06 am
In December 2023, GRAIL announced the analytical and clinical validation of a novel prognostic test in Stage I lung adenocarcinoma. About GRAIL GRAIL is a healthcare company whose mission is to detect ...
- GRAIL Announces Novel Risk Classification Test to Be Used in Lung Cancer Studyon March 18, 2024 at 6:00 am
In December 2023, GRAIL announced the analytical and clinical validation of a novel prognostic test in Stage I lung adenocarcinoma. About GRAIL GRAIL is a healthcare company whose mission is to detect ...
- Researchers aim to create AI-driven model for early detection of lung cancer riskon March 18, 2024 at 4:02 am
Researchers are developing artificial intelligence which they hope will help to identify patients most at risk of lung cancer before symptoms have even appeared.
- Savvy Senior: Who Should Be Screened for Lung Cancer?on March 18, 2024 at 2:38 am
What makes lung cancer especially tricky is that it’s often symptomless until it’s at an advanced stage, when it’s harder to treat. Early detection can lead to a 20 to 25 percent improvement in ...
- Lung Cancer Symptoms: Subtle Signs Of The Disease You Should Knowon March 17, 2024 at 9:15 am
The World Health Organisation (WHO) says that lung cancer accounts for nearly 2.21 million deaths and is one of the leading causes of cancer-related deaths. Detecting the disease early can help in ...
- Revolutionizing Cancer Detection: New Machine Learning Method Deciphers Genomic “Dark Matter”on March 16, 2024 at 5:25 am
Identifying and characterizing repeated DNA sequences, sometimes called "junk DNA" or "dark matter" within chromosomes, which may play a role in cancer or other diseases, has proven to be difficult.
- Firefighters say proposed cancer screenings will save liveson March 15, 2024 at 9:00 pm
Like most veteran firefighters, Peter Lennon knew that cancer was an occupational risk. Still, Lennon, who is the fire marshal for Manchester Fire Department, wasn't prepared for the results of a ...
- AI could help doctors detect lung cancer at earlier stageon March 15, 2024 at 8:06 am
A new AI software could help to doctors to detect lung cancer at an earlier stage and deliver more effective treatments for patients. The DOLCE study, supported by the National Institute for Health ...
- AI Detects Cancer via DNA Repeats in Liquid Biopsieson March 13, 2024 at 5:10 pm
Researchers suggest ARTEMIS strategy could offer noninvasive means of detecting and characterizing cancers, or monitoring response to anticancer therapy.
- AI may predict spread of lung cancer to brainon March 11, 2024 at 7:38 pm
Scientists trained a machine-learning algorithm to predict accurately brain metastasis using biopsy samples from early-stage non-small cell lung cancer patients. It was also highly accurate in ...
via Bing News